Log in to save to my catalogue

From Krebs to clinic: glutamine metabolism to cancer therapy

From Krebs to clinic: glutamine metabolism to cancer therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5484415

From Krebs to clinic: glutamine metabolism to cancer therapy

About this item

Full title

From Krebs to clinic: glutamine metabolism to cancer therapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Cancer, 2016-10, Vol.16 (10), p.619-634

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
Cancer cells show increased consumption of and dependence on glutamine.
Glutamine metabolism fuels the tricarboxylic acid (TCA) cycle, nucleotide and fatty acid biosynthesis, and redox balance in cancer cells.
Glutamine activates mTOR signalling, suppresses endoplasmic reticulum stress and promotes protein synthesis.
Cancer c...

Alternative Titles

Full title

From Krebs to clinic: glutamine metabolism to cancer therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5484415

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5484415

Other Identifiers

ISSN

1474-175X,1474-1768

E-ISSN

1474-1768

DOI

10.1038/nrc.2016.71

How to access this item